Should terminally ill patients have the right to take drugs that pass phase I testing? Yes

AUTOR(ES)
FONTE

BMJ Publishing Group Ltd.

RESUMO

The United States is considering allowing experimental drugs to be given to people at the end of life. Emil J Freireich believes patients should be able to judge the risks for themselves, and Dean Gesme counters that use of such drugs outside trials will damage both individuals and science

Documentos Relacionados